Loading clinical trials...
Loading clinical trials...
Open Label Single Arm Phase Ib-II Study of Pre-operative IPH2201 in Patients With Locally Advanced Resectable Squamous Cell Carcinoma of the Oral Cavity
Conditions
Interventions
IPH2201
Standard Surgery
+1 more
Locations
3
Germany
Charité University Medicine Berlin
Berlin, Germany
Instituto Catalan de Oncologia - L'Hospitalet
L'Hospitalet de Llobregat Barcelona, Spain, Spain
Hospital Universitario La Paz
Madrid, Spain
Start Date
December 1, 2014
Primary Completion Date
December 1, 2016
Completion Date
December 1, 2016
Last Updated
January 4, 2017
NCT06030440
NCT07203911
NCT04191460
NCT03370276
NCT06086925
NCT05608369
Lead Sponsor
Innate Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions